Sonja Banks

Insider Reports History

Entity
Individual
Location
C/O Fulcrum Therapeutics, Inc., 26 Landsdowne Street, Cambridge, MA
Signature
/s/ Greg Tourangeau, as attorney-in-fact for Sonja Banks
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sonja Banks:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Fulcrum Therapeutics, Inc. Director Stock Option (right to buy) 30K Jun 17, 2024 Direct

Insider Reports Filed by Sonja Banks

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FULC Fulcrum Therapeutics, Inc. Jun 17, 2024 1 $0 4 Jun 18, 2024 Director
FULC Fulcrum Therapeutics, Inc. Jun 27, 2023 1 $0 4 Jun 29, 2023 Director
FULC Fulcrum Therapeutics, Inc. Jun 27, 2022 1 $0 4 Jun 29, 2022 Director
FULC Fulcrum Therapeutics, Inc. Dec 8, 2021 1 $0 4 Dec 9, 2021 Director
FULC Fulcrum Therapeutics, Inc. Dec 8, 2021 0 $0 3 Dec 9, 2021 Director